{"cmr":"fr-cm-kg/XPAR/FR0010331421","since":null,"total":23,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-11-05","event_type":"results","title":"Innate Pharma Reports Third Quarter 2026 Business and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261104506906/en/Innate-Pharma-Reports-Third-Quarter-2026-Business-and-Financial-Update","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"z8oFYWb5fvn1Q1IyvcrMbSIG8iISL9p9ogouICL2kMcV31zCNP6C3zrfEoFxNJx8y2vNU1CU4HBuP8LBhlUXAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-10-27","event_type":"newswire_release","title":"Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261026687365/en/Innate-Pharma-PACIFIC-9-Phase-3-Trial-Readout-Timing-Updated-to-H1-2027","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"D-MKkR2Go_uUuA9lVWEwTx5rgmvGVWH9UHBqZLWjeyCP-stRkIIE4oN4VY53tthJvebtmg9kTfF4M8XpWqD0DA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-10-21","event_type":"newswire_release","title":"Innate Pharma to Participate in the Stifel Healthcare ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261020303567/en/Innate-Pharma-to-Participate-in-the-Stifel-Healthcare-Conference-and-Jefferies-Global-Healthcare-Conference","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4p5jEv4t2vGPXo1X6QJ7QiOCBL5HEpFYYjGCUGlOqlry7D4ov1e_fH9OXPZw2wQxeCs7itCIP_A75SmmpGuFCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-09-09","event_type":"newswire_release","title":"Innate Pharma organise une conférence téléphonique et un ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260909692472/fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"76BHtH0qQ9Shq7IJkWUZA47ysZd97CEmUYEXdIxurh8k7NBQYWVaSjkdbDvuXe8HY1Vvg-zxFhayJEmuBJZDDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-08-14","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1133657","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1133657","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"b0OLf_0ISgv2ZpJcanvA3aN5j4O7jJ3kSnrm5Pgko34M1ixZj2wv4WwcOYJqZT2OxxIVnsJ8pzw7Q7oTPMz6Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-08-14","event_type":"newswire_release","title":"Innate Pharma Announces Conference Call and Webcast","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260814949608/en/Innate-Pharma-Announces-Conference-Call-and-Webcast","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wf8UIAtUCj2O-ph8WLhvBrq3IeWOw3PNRjFmJkZG2ll_1AMkRVl7xQxAabPvPcijeVGVEokCZiMBP9zQwNz1Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-08-14","event_type":"newswire_release","title":"Innate Pharma Announces Pricing of €30 million Offering ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260814551740/en/Innate-Pharma-Announces-Pricing-of-€30-million-Offering-of-Ordinary-Shares","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"KEa5AFRU8xzD_FUyLGNutZUKRn--PQlpB3SYimn5NAObzd_1aYxay_woA7c7J-YtwuiwVGZaTeyefptz4QXCDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-08-13","event_type":"newswire_release","title":"Innate Pharma Announces Proposed Offering of Ordinary ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260813210915/en/Innate-Pharma-Announces-Proposed-Offering-of-Ordinary-Shares","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4Jp8gvT4gFlqKqFWUz_I_vuRk1iq00vvZXksPmw1q9xyRU4hF1CK5yoR4LHL-9-NBDFdEYF3ga4q0n0TEUBpCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-05-12","event_type":"results","title":"Innate Pharma Reports First Quarter 2026 Business Update and Financial Results","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260512637251/en/Innate-Pharma-Reports-First-Quarter-2026-Business-Update-and-Financial-Results","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ry74-6NrZqiY_4U6q8CJgOL2331Nzn1AdbrGd9MvXNnqdqpKq_SJRIHlFMluIBXVKI2AO4fAGC9QJfwcUNm-Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-05-05","event_type":"newswire_release","title":"Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260505790924/en/Innate-Pharma-Announces-Conference-Call-and-Webcast-for-Q1-2026-Business-Update","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QVgVYSKNlS3deZRPx-BdQ14PuTtQd9xQWsGTZFsTEzwHA8tBsEmDaIDdiNFSyfFYnoJmrFxcZKwY4GzHr6TFBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-04-09","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0475","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0475","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"MANO-7TpkT2Ec88MMzgNz7ivbnQNIG3YdTxvKZXxN7aGi5CGSxxQ6YDGF-D-HuK1j4xJNJw-tbY5ssjUL0t3AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-04-07","event_type":"newswire_release","title":"Innate Pharma to Present at the AACR 2026 Oncology Industry ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260407595531/en/Innate-Pharma-to-Present-at-the-AACR-2026-Oncology-Industry-Partnering-Event","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ipGaHenkgzzZHzU-5ASCGE8wNRfnh3q8aKxb9YBCTzsHiTx9_smkRbUWjEWo92TNUd3aWUrhB3d4mSGLjM2mCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-04-02","event_type":"prospectus","title":"DocumentEnregistrementUniversel [VISA]","reference":"D.26-0204","category":"VISA","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/D.26-0204","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DocumentEnregistrementUniversel; documents 2; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZXYNmMCKdhZBDliF9cUZha2UQZg319RLT_anQZOZX9-4ss12Jk8g4yAsfZn6nh1-Co337d9hSKFGy3ATVKIkCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-03-25","event_type":"results","title":"Innate Pharma Reports Full Year 2025 Financial Results and Business Update","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260325193268/en/Innate-Pharma-Reports-Full-Year-2025-Financial-Results-and-Business-Update","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"D6CSksqdr0neLit_YJiYlvJdmQfPX2tu7fJO-AJFuvimycRPazDNmEIXYemz9NaghKaWIxHq4mmXJnlLhmuCAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-19","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1089552","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1089552","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"a0BMpOk4v4i0U_KrbFE3V0KbaX6JQ2yVY4cxycXGFuy5Q4_Mqb7FZp0eCA6TET8SoPP5NCnHZt-SScBr8QXOCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-19","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1086888","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1086888","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"oyDuQ6elXIN876_yA4QfzEFKAkUyJHMJNizDhvZAUm0DLKRbc42_SUpFbK2dq3HH3tqACf6oqwwT2Nc4HPqyDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-15","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1089243","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1089243","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_jqM7f7gKbHdct1IpAJgua3HlBOe3KEZpWCarGuyN8593ExuKprA9MfVJS7JJDm7jiSzArNjgJmn2aqWT2UFDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-13","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1088617","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1088617","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pXzlbqOqOVCswCkHCBdIYcPlJhgn_IWx0cv98R6i54bIgmVsbKboe1R5-4cr3AcvrUuaZR9OygvzPbj1uUDfAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-06","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1087352","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1087352","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5T2v2du6OT_yesDZPmey_ky2-NOLQUVcRr9xjaCpfQoSBN7loo3oXS8cQ1RWhQXSbZxTvGvK9bnZgBhEpzIsCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-05","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1086859","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1086859","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5AkmrE2GMNF9fBX4oAFv4kbEXnNX77NYJfzDH_-iZltwdI9yJoW9hDppTFbLhUe3FNz0-UUgXxWKjTgmMLPpDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2026-01-02","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1086813","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1086813","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer INNATE PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FJew3r7sdTYEIXDktJM_JCiouGnObFLMthix7s6AFWgA-jmkoOZkfzlFFMWoQbkBsW6EZgLIIWXQ37p3EauSAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2025-12-10","event_type":"newswire_release","title":"Innate Pharma Releases Its 2026 Financial Calendar","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251210331629/en/Innate-Pharma-Releases-Its-2026-Financial-Calendar","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2vmCFAJ_m9nU2k9gQWaoadKJTk7LQndOMgAXGWBFwmCnjV5IWFo9cCU83aH-IJe0D0tXs7DgclFzG-nAroaQBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0010331421","date":"2025-11-09","event_type":"newswire_release","title":"Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251109757297/en/Innate-Pharma-Announces-FDA-Clearance-to-Proceed-With-TELLOMAK-3-a-Confirmatory-Phase-3-Trial-of-Lacutamab-in-CTCL","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NMtiuFRgf2vrtOSms-zYCekA0Eh_Tp-Nq8Y5TmT5liskvdfgaIUPypSTXtrjhDMnJOA4q6ofG1ePq6k3jwKoCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}